Sentinel lymph node biopsy techniques in thyroid pathologies - A meta-analysis

Endokrynologia Polska

Volumn 63, Issue 3, 2012, Pages 222-231

  Kaczka, Krzysztof ^a   Celnik, Agnieszka ^a   Luks, Bartosz ^a   Jasion, Jakub ^a   Pomorski, Lech ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Dye method; Elective lymphadenectomy; Radioisotope method; Selective lymphadenectomy; Sentinel lymph node; Thyroid cancer

Indexed keywords

BLUE DYE; DYE; RADIOISOTOPE; UNCLASSIFIED DRUG;

BIOPSY TECHNIQUE; CANCER RECURRENCE; CHEMICAL LABELING; DIAGNOSTIC ACCURACY; ELECTIVE SURGERY; HISTOPATHOLOGY; HUMAN; ISOTOPE LABELING; LYMPHADENECTOMY; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE METASTASIS; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; THYROID CANCER;

COLORING AGENTS; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; METHYLENE BLUE; PREDICTIVE VALUE OF TESTS; RADIOIMMUNODETECTION; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; THYROID NEOPLASMS;

EID: 84864541159     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Bhattacharyya N. A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma. Otolaryngol Head Neck Surg 2003; 128: 115-123. (Pubitemid 36246129)
2. Steinmuller T, Klupp J, Rayes N et al. Prognostic factors in patients with differentiated thyroid carcinoma. Eur J Surg 2000; 166: 29-33. (Pubitemid 30062584)
3. Ward LS, Souza SL, Assumpcao LV. The impact of nodal metastases on prognosis of well-differentiated thyroid cancer suggests the practice of prophylactic neck dissection. Arch Otolaryngol Head Neck Surg 2003; 129: 495-496. (Pubitemid 36417909)
4. Jarza̧b B. Treatment of thyroid cancer (in Polish) Pol J Endocrinol 1995; 46 (Suppl 1): 25-35.
5. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1998; 104: 947-953.
6. Rossi R, Cady B, Silverman M et al. Current results of conservative surgery for differentiated thyroid carcinoma. World J Surg 1986; 10: 621-622.
7. Dralle H, Gimm O. Lymph node in thyroid carcinoma (in German). Chirurg 1996; 67: 788-806.
8. Beasley NJ, Lee J, EskiI S et al. Impact of nodal metastases on prognosis in patients with well-differentiated thyroid cancer. Arch Otolaryngol Head Neck Surg 2002; 128: 825-828. (Pubitemid 34755316)
9. McHenry CR, Rosen IB, Walfish PG. Prospective management of nodal metastases in differentiated thyroid cancer. Am J Surg 1991; 162: 353-356.
10. Weber T, Amann K, Weckauf H et al. Detection of disseminated medullary thyroid carcinoma cells in cervical lymph nodes by cytokeratin 20 reverse transcription-polymerase chain reaction. World J Surg 2002; 26: 148-152. (Pubitemid 36920424)
11. Witte J, Goretzki PE, Dicken J et al. Importance of lymph node metastases in follicular thyroid cancer. World J Surg 2002; 26: 1017-1022. (Pubitemid 36920302)
12. Pomorski L. Operations of cervical lymph nodes in patients with differentiated thyroid cancer, selective or elective lymphadenectomy (in Polish). Wiad Lek 2001; 54 (Suppl 1): 198-204.
13. Roh JL, Park JY, Park CI. Prevention of postoperative hypocalcemia with routine oral calcium and vitamin D supplements in patients with differentiated papillary thyroid carcinoma undergoing total thyreoidectomy plus central neck dissection. Cancer 2009; 115: 251-258.
14. Bergenfelz A, Jansson S, Kristofferson A et al. Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3660 patients. Langenbecks' Arch Surg 2008; 393: 667-673.
15. Shen WT, Ogawa L, Ruan D et al. Central neck lymph node dissection for papillary thyroid cancer: the reliability of surgeon judgement in predicting which patients will benefit. Surgery 2010; 148: 398-403.
16. Raijmakers PGHM, Paul MA, Lips P. Sentinel Node Detection in Patients with Thyroid Carcinoma: A Meta-analysis. World J Surg 2008; 32: 1961-1967.
17. Balasubramanian SP, Harrison BJ. Systematic review and meta-analysis of sentinel node biopsy in thyroid cancer. Br J Surg 2011; 98: 334-344
18. Morton DI, Wen DR, Wong JH et al Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-399.
19. Stojadinovic A, Allen PJ, Protic M et al. Colon sentinel lymph node mapping: practical surgical applications. J Am Coll Surg 2005; 201: 297-313. (Pubitemid 40994964)
20. Bertagnolli M, Miedema B, Redston M et al. Sentinel node staging of resectable colon cancer: results of a multicenter study. Ann Surg 2004; 240: 624-630. (Pubitemid 39281285)
21. Roukos DH. Current status and future perspectives in gastric cancer management. Cancer Treat Rev 2000; 26: 243-245.
22. Kitagawa Y, Fujii H, Kumai K et al. Recent advances in sentinel node navigation for gastric cancer: a paradigm shift of surgical management. J Surg Oncol 2005; 90: 147-152.
23. Kitagawa Y, Fujii H, Mukai M et al. The role of the sentinel lymph node in gastrointestinal cancer. Surg Clin North Am 2000; 80: 799-809.
24. Yasuda S, Shimada H, Chino Q et al. Sentinel lymph node detection with Tc-99m tin colloids in patients with esophagogastric cancer (in Japanese). J Clin Oncol 2003; 33: 68-72. (Pubitemid 43115270)
25. Lamb PJ, Griffin SM, Burt AD et al. Sentinel node biopsy to evaluate the metastatic dissemination of oesophageal adenocarcinoma. Br J Surg 2005; 92: 60-67. (Pubitemid 40144196)
26. Ross GL, Soutar DS, MacDonald DG et al. Sentinel node biopsy in head and neck cancer: preliminary results of a multicenter trial. Ann Surg Oncol 2004; 11: 690-696. (Pubitemid 40486704)
27. Ross G, Soutar DS, MacDonald DG et al. Improved staging of cervical metastases in clinically node-negative patients with head and neck squamous cell carcinoma. Ann Surg Oncol 2004; 11: 213-218. (Pubitemid 40486799)
28. Ross G, Shoaib T, Soutar DS et al. The use of sentinel node biopsy to upstage the clinically N0 neck in head and neck cancer. Arch Otolaryngol Head Neck Surg 2002; 128: 1287-1291. (Pubitemid 35403308)
29. Little AG, Dehoyos A, Kirgan DM et al. Intraoperative lymphatic mapping for non-small cell lung cancer: the sentinel node technique. J Thorac Cardiovasc Surg 1999; 117: 220-224. (Pubitemid 29068376)
30. Lardinois D, Brack T, Gaspert A et al. Bronchoscopic radioisotope injection for sentinel lymph-node mapping in potentially resectable non small-cell lung cancer. Eur J Cardiothorac Surg 2003; 23: 824-827. (Pubitemid 36566581)
31. Liptay MJ, Masters GA, Winchester DJ et al. Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer. Ann Thorac Surg 2000; 70: 384-389.
32. Melfi FM, Chella A, Menconi GF et al. Intraoperative radioguided sentinel lymph node biopsy in non-small cell lung cancer. Eur J Cardiothorac Surg 2003; 23: 214-220. (Pubitemid 36143784)
33. Di Stefano AB,Acquaviva G, Garozzo G et al. Lymph node mapping and sentinel node detection in patients with cervical carcinoma: a 2-year experience. Gynecol Oncol 2005; 99: 671-679. (Pubitemid 41686552)
34. Dhar KK, Woolas RP. Lymphatic mapping and sentinel node biopsy in early vulvar cancer. BJOG 2005; 112: 696-702. (Pubitemid 40852834)
35. Kelemen PR, Van Herle AJ, Giuliano AE. Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch Surg 1998; 133: 288-292. (Pubitemid 28154991)
36. Gallowitsch HJ, Mikosch P, Kresnik E et al. Lymphoscintigraphy and gamma probe-guided surgery in papillary thyroid carcinoma: the sentinel lymph node concept in thyroid carcinoma Clin Nucl Med 1999; 24: 744-746. (Pubitemid 29449627)
37. Rettenbacher L, Sungler R P, Gmeiner D et al. Detecting the sentinel lymph node in patients with differentiated thyroid carcinoma. Eur J Nucl Med 2000; 27: 1399-1401.
38. Moher D, Liberati A, Tetzlaff J et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010; 8: 336-341.
39. Bae JS, Park WC, Song BJ et al Endoscopic thyroidectomy and sentinel lymph node biopsy via an anterior chest approach for papillary thyroid cancer. Surg Today 2009; 39: 178-181.
40. Dixon E, Mckinnon JG, Pasieka JL. Feasibility of sentinel lymph node biopsy and lymphatic mapping in nodular thyroid neoplasms. World J Surg 2000; 24: 1396-1401.
41. Arch-Ferrer J, Velazquez D, Fajardo R et al. Accuracy of sentinel lymph node in papillary thyroid carcinoma. Surgery 2001; 130: 907-913. (Pubitemid 34014553)
42. Pelizzo MR, Boschin IM, Toniato A et al. The sentinel node procedure with Patent Blue V dye in the surgical treatment of papillary thyroid carcinoma. Acta Otolaryngol 2001; 121: 421-424.
43. Fukui Y, Yamakawa T, Taniki T et al. Sentinel lymph node biopsy in patients with papillary thyroid carcinoma. Cancer 2001; 1: 2868-2874.
44. Tsugawa K, Ohnishi I, Nakamura M et al. Intraoperative lymphatic mapping and sentinel lymph node biopsy in patients with papillary carcinoma of the thyroid gland. Biomed Pharmacother 2002; 56 (Suppl 1): 100s-103s. (Pubitemid 35448028)
45. Takami H, Sasaki K, Ikeda Y et al. Detection of sentinel lymph nodes in patients with papillary thyroid cancer. Asian J Surg 2003; 26: 145-158.
46. Chow TL, Lim BH, Kwok SP. Sentinel lymph node dissection in papillary thyroid carcinoma. ANZ J Surg 2004; 74: 10-12. (Pubitemid 38250558)
47. Peparini N, Maturo F, Di Matteo FM et al. Marchesi F. Blue-dye Sentinel Node Mapping in Thyroid Carcinoma: Detatable Results of Feasibility. Acta Chir Belg 2006; 106: 523-527. (Pubitemid 44785705)
48. Rubello D, Nanni C, Boschin M et al. Sentinel Lymph Node (SLN) Procedure with Patent V Blue Dye in 153 Patients with Papillary Thyroid Carcinoma (PTC): Is It an Acccurate Staging Method. J. Exp. Clin Cancer Res 2006; 25: 483-486.
49. Dzodic R, Markovic I, Inic M et al. Sentinel lymph node biopsy may be used to support the decision to perform modified radical neck dissection in differentiated thyroid carcinoma. World J Surg 2006; 30: 841-846.
50. Abdalla HM. Feasibility of sentinel lymph node detection in nodular thyroid disease. J Egypt Natl Canc Inst 2006; 18: 35-40.
51. Roh JL, Park CL. Sentinel lymph node biopsy as guidance for central neck dissection in patients with papillary thyroid carcinoma. Cancer 2008; 113: 1527-1531.
52. Wang JD, Deng XC, Jin XJ et al. Surgical exploration of the sentinel lymph nodes in the papillary thyroid carcinoma (article in French). Rev Laryngol Otol Rhin (Bord) 2008; 129: 285-287.
53. Takeyama H, Tabei I, Uchida K et al. Sentinel node biopsy for follicular tumours of the thyroid gland. Br J Surg 2009; 96: 490-495.
54. Anand SM, Gologan O, Rochon L et al. The Role of Sentinel Lymph Node Biopsy in Differentiated Thyroid Carcinoma. Arch Otolaryngol Head Neck Surg 2009; 135: 1199-1204.
55. Cunningham DK, Yao KA, Turner RR et al. Sentinel lymph node biopsy for papillary thyroid cancer: 12 years of experience at a single institution. Ann Surg Oncol 2010; 17: 2970-2975.
56. Stoeckli SJ, Pfaltz M, Steinert H et al. Sentinel lymph node biopsy in thyroid tumors: a pilot study. Eur Arch Otorhinolaryngol 2003; 260: 364-368. (Pubitemid 37100679)
57. Pelizzo MR, Rubello D, Boschin IM et al. Contribution of SLN investigation with 99mTc-nanocolloid in clinical satging of thyroid cancer: technical feasibility. Eur J Nucl Med Mol Imaging 2007; 34: 934-893.
58. Carcoforo P, Feggi L, Trasforini G et al. Use of preoperative lymphoscintigraphy and intraoperative gamma-probe detection for identification of the sentinel lymph node in patients with papillary thyroid carcinoma. EJSO 2007; 33: 1075-1080. (Pubitemid 350002345)
59. Boschin IM, Toniato A, Piotto A et al. 99Tc Nanocolloid sentinel node procedure in thyroid carcinoma. Langenbecks Arch Surg 2008; 393: 705-708.
60. Catarci M, Zaraca F, Angeloni R et al. Preoperative Lymphoscintigraphy and Sentinel Lymph Node Biopsy in Papillary Thyroid Cancer. A Pilot Study. J. Surg Oncol 2001; 77: 21-24. (Pubitemid 32382012)
61. Lee SK, Choi JH, Lim HI et al. Sentinel lymph node biopsy in papillary thyroid cancer. Comparison study of blue dye method and combined radioisotope and blue dye method in papillary thyroid cancer. EJSO 2009; 35: 974-979.
62. Sahin M, Yapici O, Dervisoglu A et al. Evaluation of lymphatic drainage of cold thyroid nodules with intratumoral injection of Tc-99m nanocolloid. Clin Nucl Med 2001; 26: 602-605. (Pubitemid 32565884)
63. Kaczka K, Jakubiak-Wielganowicz M, Zawlik I et al. Nodal status in the papillary thyroid cancer: Comparison of the results of routine histopathological examination, immunohistochemistry and reverse transcription-polymerase chain reaction. Neoplasma 2008; 55: 513-518.
64. Pomorski L, Kaczka K, Piaskowski S et al. Detection of lymph node metastases of papillary thyroid cancer - comparison of the results of histopathology, immunohistochemistry and reverse transcription - polymerase chain reaction - a preliminary report. Langenbecks Arch Surg 2005; 390: 209-215. (Pubitemid 40884230)
65. Li X, Wang J, Zhou Z Experimental study of sentinel node biopsy in thyroid by using three kinds of vital dyes at different concentration and dose. (article in Chinese). Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2007; 21: 988-990.
66. Ducci M, Appetecchia M, Marzetti M. Neck dissection for surgical treatment of lymphnode metastasis in papillary thyroid carcinoma. J Exp Clin Cancer Res 1997; 16: 333-335. (Pubitemid 27454945)
67. Machens A, Holzhausen HJ, Dralle H. Skip Metastases in Thyroid Cancer Leaping the Central Lymph Node Compartment. Arch Surg 2004; 139: 43-45. (Pubitemid 38049617)
68. Barthelmes L, Goyal A, Newcombe RG et al. Adverse reactions to patent blue V dye. The NEW START and ALMANAC experience. Eur J Surg Oncol 2010; 36: 399-403.
69. Montgomery LL, Thorme AC, Van Zee KJ et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg 2002; 95: 385-388. (Pubitemid 34793105)
70. Chen SL, Iddings DM, Scheri RP et al. Lymphatic mapping and Sentinel Node Analysis: Current Concepts and Applications. CA Cancer J Clin 2006; 56: 292-309. (Pubitemid 44527491)
71. Barczyński M. Systematic review and meta-analysis of sentinel node biopsy in thyroid cancer (Br J Surg 2010; 98: 334-344). Br J Surg 2011; 98: 344-345.